A citation-based method for searching scientific literature

Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky, Weiping Jia. Diabetes Care 2018
Times Cited: 150







List of shared articles



Times cited

Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Norihiro Kuroda, Yoshiki Kusunoki, Keiko Osugi, Mana Ohigashi, Daisuke Azuma, Hiroki Ikeda, Shinya Makino, Akihito Otsuka, Daisuke Tamada, Nobuaki Watanabe,[...]. J Diabetes Investig 2021
5


Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
Mana Ohigashi, Keiko Osugi, Yoshiki Kusunoki, Kahori Washio, Satoshi Matsutani, Taku Tsunoda, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno, Mitsuyoshi Namba,[...]. J Diabetes Investig 2021
1

Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).
Thomas W Martens, Richard M Bergenstal, Teresa Pearson, Anders L Carlson, Gary Scheiner, Campos Carlos, Birong Liao, Kristen Syring, Roy Daniel Pollom. Postgrad Med 2021
0

Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
Sara Hallström, Irl B Hirsch, Magnus Ekelund, Sheyda Sofizadeh, Henrik Albrektsson, Solveig Dahlqvist, Ann-Marie Svensson, Marcus Lind. Diabetes Technol Ther 2021
1

Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura, Shinichiro Kawata, Hajime Sugawara, Jun Takeuchi, So Nagai, Kazuno Omori, Kazuhisa Tsuchida, Aika Miya,[...]. J Diabetes Investig 2021
0

Time in range centered diabetes care.
Klemen Dovc, Tadej Battelino. Clin Pediatr Endocrinol 2021
6

The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes.
Min Young Kim, Gyuri Kim, Ji Yun Park, Min Sun Choi, Ji Eun Jun, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim. Diabetes Technol Ther 2021
1


Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus.
Philip Levin, Byron J Hoogwerf, Janet Snell-Bergeon, Tim Vigers, Laura Pyle, Lee Bromberger. Endocr Pract 2021
2

Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes.
Satomi Wakasugi, Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Keiko Nishida, Toshihiko Shiraiwa, Keiichi Torimoto, Akira Kurozumi,[...]. BMJ Open Diabetes Res Care 2021
2

Time-in-range for monitoring glucose control: Is it time for a change?
Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar-Taibo, Francisco Javier Ampudia-Blasco. Diabetes Res Clin Pract 2021
0


Time in Range as a Research Outcome Measure.
Joseph G Timmons, James G Boyle, John R Petrie. Diabetes Spectr 2021
0

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
Jingyi Lu, Chunfang Wang, Jinghao Cai, Yun Shen, Lei Chen, Lei Zhang, Wei Lu, Wei Zhu, Gang Hu, Tian Xia,[...]. J Clin Endocrinol Metab 2021
0